Cargando…

Exosome microRNA signatures in patients with complex regional pain syndrome undergoing plasma exchange

BACKGROUND: Therapeutic plasma exchange (PE) or plasmapheresis is an extracorporeal procedure employed to treat immunological disorders. Exosomes, nanosized vesicles of endosomal origin, mediate intercellular communication by transferring cargo proteins and nucleic acids and regulate many pathophysi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramanathan, Sujay, Douglas, Sabrina R., Alexander, Guillermo M., Shenoda, Botros B., Barrett, James E., Aradillas, Enrique, Sacan, Ahmet, Ajit, Seena K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419338/
https://www.ncbi.nlm.nih.gov/pubmed/30871575
http://dx.doi.org/10.1186/s12967-019-1833-3
_version_ 1783403921852596224
author Ramanathan, Sujay
Douglas, Sabrina R.
Alexander, Guillermo M.
Shenoda, Botros B.
Barrett, James E.
Aradillas, Enrique
Sacan, Ahmet
Ajit, Seena K.
author_facet Ramanathan, Sujay
Douglas, Sabrina R.
Alexander, Guillermo M.
Shenoda, Botros B.
Barrett, James E.
Aradillas, Enrique
Sacan, Ahmet
Ajit, Seena K.
author_sort Ramanathan, Sujay
collection PubMed
description BACKGROUND: Therapeutic plasma exchange (PE) or plasmapheresis is an extracorporeal procedure employed to treat immunological disorders. Exosomes, nanosized vesicles of endosomal origin, mediate intercellular communication by transferring cargo proteins and nucleic acids and regulate many pathophysiological processes. Exosomal miRNAs are potential biomarkers due to their stability and dysregulation in diseases including complex regional pain syndrome (CRPS), a chronic pain disorder with persistent inflammation. A previous study showed that a subset of CRPS patients responded to PE. METHODS: As a proof-of-concept, we investigated the PE-induced exosomal miRNA changes in six CRPS patients. Plasma cytokine levels were measured by HPLC and correlated with miRNA expression. Luciferase assay following co-transfection of HEK293 cells with target 3′UTR constructs and miRNA mimics was used to evaluate miRNA mediated gene regulation of target mRNA. Transient transfection of THP-1 cells with miRNA mimics followed by estimation of target gene and protein expression was used to validate the findings. RESULTS: Comparison of miRNAs in exosomes from the serum of three responders and three poor-responders showed that 17 miRNAs differed significantly before and after therapy. Of these, poor responders had lower exosomal hsa-miR-338-5p. We show that miR-338-5p can bind to the interleukin 6 (IL-6) 3′ untranslated region and can regulate IL-6 mRNA and protein levels in vitro. PE resulted in a significant reduction of IL-6 in CRPS patients. CONCLUSIONS: We propose that lower pretreatment levels of miR-338-5p in poor responders are linked to IL-6 levels and inflammation in CRPS. Our data suggests the feasibility of exploring exosomal miRNAs as a strategy in patient stratification for maximizing therapeutic outcome of PE. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12967-019-1833-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6419338
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64193382019-03-27 Exosome microRNA signatures in patients with complex regional pain syndrome undergoing plasma exchange Ramanathan, Sujay Douglas, Sabrina R. Alexander, Guillermo M. Shenoda, Botros B. Barrett, James E. Aradillas, Enrique Sacan, Ahmet Ajit, Seena K. J Transl Med Research BACKGROUND: Therapeutic plasma exchange (PE) or plasmapheresis is an extracorporeal procedure employed to treat immunological disorders. Exosomes, nanosized vesicles of endosomal origin, mediate intercellular communication by transferring cargo proteins and nucleic acids and regulate many pathophysiological processes. Exosomal miRNAs are potential biomarkers due to their stability and dysregulation in diseases including complex regional pain syndrome (CRPS), a chronic pain disorder with persistent inflammation. A previous study showed that a subset of CRPS patients responded to PE. METHODS: As a proof-of-concept, we investigated the PE-induced exosomal miRNA changes in six CRPS patients. Plasma cytokine levels were measured by HPLC and correlated with miRNA expression. Luciferase assay following co-transfection of HEK293 cells with target 3′UTR constructs and miRNA mimics was used to evaluate miRNA mediated gene regulation of target mRNA. Transient transfection of THP-1 cells with miRNA mimics followed by estimation of target gene and protein expression was used to validate the findings. RESULTS: Comparison of miRNAs in exosomes from the serum of three responders and three poor-responders showed that 17 miRNAs differed significantly before and after therapy. Of these, poor responders had lower exosomal hsa-miR-338-5p. We show that miR-338-5p can bind to the interleukin 6 (IL-6) 3′ untranslated region and can regulate IL-6 mRNA and protein levels in vitro. PE resulted in a significant reduction of IL-6 in CRPS patients. CONCLUSIONS: We propose that lower pretreatment levels of miR-338-5p in poor responders are linked to IL-6 levels and inflammation in CRPS. Our data suggests the feasibility of exploring exosomal miRNAs as a strategy in patient stratification for maximizing therapeutic outcome of PE. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12967-019-1833-3) contains supplementary material, which is available to authorized users. BioMed Central 2019-03-14 /pmc/articles/PMC6419338/ /pubmed/30871575 http://dx.doi.org/10.1186/s12967-019-1833-3 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Ramanathan, Sujay
Douglas, Sabrina R.
Alexander, Guillermo M.
Shenoda, Botros B.
Barrett, James E.
Aradillas, Enrique
Sacan, Ahmet
Ajit, Seena K.
Exosome microRNA signatures in patients with complex regional pain syndrome undergoing plasma exchange
title Exosome microRNA signatures in patients with complex regional pain syndrome undergoing plasma exchange
title_full Exosome microRNA signatures in patients with complex regional pain syndrome undergoing plasma exchange
title_fullStr Exosome microRNA signatures in patients with complex regional pain syndrome undergoing plasma exchange
title_full_unstemmed Exosome microRNA signatures in patients with complex regional pain syndrome undergoing plasma exchange
title_short Exosome microRNA signatures in patients with complex regional pain syndrome undergoing plasma exchange
title_sort exosome microrna signatures in patients with complex regional pain syndrome undergoing plasma exchange
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419338/
https://www.ncbi.nlm.nih.gov/pubmed/30871575
http://dx.doi.org/10.1186/s12967-019-1833-3
work_keys_str_mv AT ramanathansujay exosomemicrornasignaturesinpatientswithcomplexregionalpainsyndromeundergoingplasmaexchange
AT douglassabrinar exosomemicrornasignaturesinpatientswithcomplexregionalpainsyndromeundergoingplasmaexchange
AT alexanderguillermom exosomemicrornasignaturesinpatientswithcomplexregionalpainsyndromeundergoingplasmaexchange
AT shenodabotrosb exosomemicrornasignaturesinpatientswithcomplexregionalpainsyndromeundergoingplasmaexchange
AT barrettjamese exosomemicrornasignaturesinpatientswithcomplexregionalpainsyndromeundergoingplasmaexchange
AT aradillasenrique exosomemicrornasignaturesinpatientswithcomplexregionalpainsyndromeundergoingplasmaexchange
AT sacanahmet exosomemicrornasignaturesinpatientswithcomplexregionalpainsyndromeundergoingplasmaexchange
AT ajitseenak exosomemicrornasignaturesinpatientswithcomplexregionalpainsyndromeundergoingplasmaexchange